Fort Washington Investment Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.52M | Sell |
28,866
-176
| -0.6% | -$26.4K | 0.02% | 241 |
|
|
2026
Q1 | $4.44M | Sell |
29,042
-295
| -1% | -$45.2K | 0.02% | 243 |
|
|
2025
Q4 | $4.04M | Sell |
29,337
-191
| -0.6% | -$25K | 0.02% | 238 |
|
|
2025
Q3 | $3.79M | Sell |
29,528
-647
| -2% | -$78.9K | 0.02% | 236 |
|
|
2025
Q2 | $3.65M | Sell |
30,175
-1,050
| -3% | -$118K | 0.02% | 233 |
|
|
2025
Q1 | $3.48M | Sell |
31,225
-1,610
| -5% | -$171K | 0.02% | 233 |
|
|
2024
Q4 | $3.2M | Sell |
32,835
-1,090
| -3% | -$116K | 0.02% | 233 |
|
|
2024
Q3 | $3.9M | Sell |
33,925
-700
| -2% | -$79.4K | 0.02% | 227 |
|
|
2024
Q2 | $3.69M | Sell |
34,625
-60,692
| -64% | -$6.09M | 0.02% | 229 |
|
|
2024
Q1 | $9.22M | Sell |
95,317
-550
| -0.6% | -$56.4K | 0.06% | 210 |
|
|
2023
Q4 | $9.68M | Sell |
95,867
-231
| -0.2% | -$22.3K | 0.07% | 203 |
|
|
2023
Q3 | $9.79M | Sell |
96,098
-1,084
| -1% | -$110K | 0.07% | 201 |
|
|
2023
Q2 | $9.81M | Sell |
97,182
-396
| -0.4% | -$39.6K | 0.07% | 202 |
|
|
2023
Q1 | $8.98M | Hold |
97,578
| – | – | 0.07% | 206 |
|
|
2022
Q4 | $8.85M | Sell |
97,578
-522
| -0.5% | -$44K | 0.07% | 203 |
|
|
2022
Q3 | $7.46M | Sell |
98,100
-2,514
| -2% | -$208K | 0.06% | 211 |
|
|
2022
Q2 | $8.51M | Sell |
100,614
-2,450
| -2% | -$215K | 0.07% | 204 |
|
|
2022
Q1 | $9.04M | Sell |
103,064
-100
| -0.1% | -$8.66K | 0.06% | 206 |
|
|
2021
Q4 | $9.02M | Sell |
103,164
-5,159
| -5% | -$428K | 0.05% | 213 |
|
|
2021
Q3 | $8.86M | Sell |
108,323
-300
| -0.3% | -$27K | 0.06% | 216 |
|
|
2021
Q2 | $9.91M | Sell |
108,623
-2,120
| -2% | -$189K | 0.09% | 205 |
|
|
2021
Q1 | $9.47M | Sell |
110,743
-3,700
| -3% | -$332K | 0.09% | 202 |
|
|
2020
Q4 | $10.8M | Sell |
114,443
-870
| -0.8% | -$76K | 0.11% | 130 |
|
|
2020
Q3 | $10M | Sell |
115,313
-28,693
| -20% | -$2.49M | 0.11% | 120 |
|
|
2020
Q2 | $12.6M | Sell |
144,006
-705,355
| -83% | -$60.9M | 0.14% | 113 |
|
|
2020
Q1 | $70M | Buy |
849,361
+83,921
| +11% | +$7.49M | 0.95% | 30 |
|
|
2019
Q4 | $72.5M | Sell |
765,440
-281,498
| -27% | -$25.3M | 0.77% | 34 |
|
|
2019
Q3 | $91M | Sell |
1,046,938
-370,777
| -26% | -$33.3M | 1.01% | 26 |
|
|
2019
Q2 | $129M | Sell |
1,417,715
-337,587
| -19% | -$28.6M | 1.44% | 13 |
|
|
2019
Q1 | $151M | Sell |
1,755,302
-416,232
| -19% | -$33.4M | 1.7% | 10 |
|
|
2018
Q4 | $167M | Sell |
2,171,534
-82,992
| -4% | -$6.46M | 2.04% | 7 |
|
|
2018
Q3 | $174M | Buy |
2,254,526
+12,822
| +0.6% | +$948K | 1.72% | 9 |
|
|
2018
Q2 | $152M | Buy |
2,241,704
+255,618
| +13% | +$17.6M | 1.53% | 9 |
|
|
2018
Q1 | $144M | Buy |
1,986,086
+16,785
| +0.9% | +$1.28M | 1.49% | 11 |
|
|
2017
Q4 | $148M | Buy |
1,969,301
+104,890
| +6% | +$7.91M | 1.47% | 11 |
|
|
2017
Q3 | $143M | Buy |
1,864,411
+5,337
| +0.3% | +$403K | 2.22% | 6 |
|
|
2017
Q2 | $139M | Buy |
1,859,074
+1,531
| +0.1% | +$109K | 2.19% | 7 |
|
|
2017
Q1 | $124M | Buy |
1,857,543
+37,741
| +2% | +$2.51M | 1.99% | 9 |
|
|
2016
Q4 | $119M | Buy |
1,819,802
+209,581
| +13% | +$13.6M | 1.98% | 12 |
|
|
2016
Q3 | $114M | Buy |
1,610,221
+7,983
| +0.5% | +$582K | 2.04% | 12 |
|
|
2016
Q2 | $118M | Buy |
1,602,238
+47,088
| +3% | +$3.25M | 2.21% | 10 |
|
|
2016
Q1 | $101M | Buy |
1,555,150
+151,436
| +11% | +$10.3M | 1.96% | 11 |
|
|
2015
Q4 | $108M | Buy |
1,403,714
+221,048
| +19% | +$17.6M | 2.18% | 10 |
|
|
2015
Q3 | $97.4M | Buy |
1,182,666
+18,745
| +2% | +$1.67M | 2.02% | 13 |
|
|
2015
Q2 | $103M | Buy |
1,163,921
+78,274
| +7% | +$7.18M | 1.92% | 14 |
|
|
2015
Q1 | $95.9M | Buy |
1,085,647
+30,634
| +3% | +$2.72M | 1.91% | 15 |
|
|
2014
Q4 | $87.6M | Buy |
1,055,013
+624,333
| +145% | +$51.8M | 1.77% | 15 |
|
|
2014
Q3 | $36.3M | Sell |
430,680
-10,832
| -2% | -$876K | 0.76% | 39 |
|
|
2014
Q2 | $35.8M | Sell |
441,512
-9,625
| -2% | -$757K | 0.7% | 41 |
|
|
2014
Q1 | $34.4M | Sell |
451,137
-31,333
| -6% | -$2.28M | 0.74% | 40 |
|
|
2013
Q4 | $34.8M | Sell |
482,470
-19,202
| -4% | -$1.33M | 0.78% | 36 |
|
|
2013
Q3 | $34.5M | Buy |
501,672
+5,215
| +1% | +$345K | 0.83% | 33 |
|
|
2013
Q2 | $31.5M | Buy |
+496,457
| New | +$32.3M | 0.72% | 31 |
|
Other funds holding NVS
SI
CPC
KAS
GGI
FWCM
QCM
DADC
Fort Washington Investment Advisors's NVS Position: Q2 2026 in Review
Fort Washington Investment Advisors reduced its Novartis (NVS) stake by 0.61% in Q2 2026, selling an estimated $26.4K and leaving 28,866 shares worth $4.52M. The position accounts for 0.02% of the portfolio, ranked #241.
Fort Washington Investment Advisors first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $174M in Q3 2018. 652 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Fort Washington Investment Advisors held 28,866 shares of Novartis worth $4.52M as of Q2 2026.
- Fort Washington Investment Advisors sold 176 Novartis shares in Q2 2026, an estimated $26.4K.
- Novartis made up 0.02% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #241 holding.
- Fort Washington Investment Advisors first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- Fort Washington Investment Advisors's Novartis position peaked at $174M in Q3 2018.
- 652 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.